Narita S, Yanagisawa T, Hatakeyama S, Fukuokaya W, et al. The Impact of Early Modification of Upfront Androgen Receptor Signaling Inhibitors on Survival Outcomes in Metastatic Hormone-Sensitive Prostate Cancer. Prostate 2025 Nov 6. doi: 10.1002/pros.70092.
PMID: 41195461